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This sensitive approach can unravel complex chromosomal 
abnormalities in patient samples with a limited amount of 
aberrant cells and may lead to better diagnostic and thera-
peutic options.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Chromosomal aberrations play a key role in malignant 
transformation and are frequently found in cancer cells 
using cytogenetic approaches. These chromosomal 
changes may lead to alteration of gene function and 
thereby presumably play a key role in malignant transfor-
mation  [1] . So far, only few of these aberrations have been 
characterized at the molecular level, particularly in solid 
tumours. Many of these genomic alterations like inver-
sions or translocations are accompanied by some loss or 
gain of genetic material. The combination of fine tiling 
comparative genomic hybridization (FT-CGH) and liga-
tion-mediated PCR (LM-PCR) allows the molecular 
characterization of such alterations. FT-CGH detects ge-
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 Abstract 
 Chromosomal abnormalities, like deletions, amplifications, 
inversions or translocations, are recurrent features in haema-
tological malignancies. However, the precise molecular 
breakpoints are frequently not determined. Here we de-
scribe a rapid analysis of genetic imbalances combining fine 
tiling comparative genomic hybridization (FT-CGH) and liga-
tion-mediated PCR (LM-PCR). We clarified an inv(14)(q11q32) 
in a case of T cell acute lymphoblastic leukaemia with a 
breakpoint in the  TRA/D in 68% of cells detected by fluores-
cence in situ hybridization. FT-CGH showed several mono- 
and biallelic losses within  TRA/D . LM-PCR disclosed a  TRA/D 
rearrangement on one allele. The other allele revealed an 
inv(14)(q11q32), joining  TRDD2 at 21,977,000 of 14q11 togeth-
er with the  IGH locus at 105,948,000 and 3  -sequence of  TRAC 
at 22,092,000 joined together with  IGHV4–61 at 106,166,000. 
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nomic imbalances like deletions or amplifications and 
LM-PCR enables the precise molecular characterization 
of the molecular breakpoints. Using these techniques we 
characterized selected genomic areas, including the loci 
of the T cell receptor   /  (TRA/D) and immunoglobulin 
heavy chain  (IGH), and were able to clarify an inv(14)
(q11q32) in a T cell acute lymphoblastic leukaemia (T-
ALL) sample. This sensitive approach allows the clarifica-
tion of even complex chromosomal abnormalities and 
can unravel involved genes. This knowledge may lead to 
a better understanding of pathogenetic aspects and may 
open new diagnostic and therapeutic options.
 Material and Methods 
 Fine Tiling Comparative Genomic Hybridization 
 Aberrant genomic areas play a more and more important role 
in the clarification of alteration gene expressions. Since chromo-
somal translocations involving the  TRA/D locus are usually ac-
companied by DNA losses due to V(D)J recombinations  [1] , we 
assumed that using FT-CGH and LM-PCR allows the detection of 
unknown translocation partners. For this analysis we used ge-
nomic DNA of a male patient (24 years of age) with a diagnosis of 
a mature T-ALL. Immunophenotyping of the peripheral blood 
cells revealed 49% of blast cells, which were positive for CD5, CD7, 
cyCD3, sCD3, CD8, TdT, CD52, TCRg/d. Chromosome R-band-
ing analysis of the tumor cells at initial diagnosis revealed
the karyotype: 46,t(X;5)(q26;q33),Y,del(1)(p3?4p3?5),add(11)(q13),
der(12)t(12;18)(p13;q12)add(12)(q21),inv(14)(q11q32), add(17)(p11) 
[cp18]/46,XY. The patient was treated according to the ALL pro-
tocol, but died 8 weeks after diagnosis. In this study, the loci of 
 TRA/D and  IGH were analyzed by a custom-designed high-reso-
lution fine-tiling oligonucleotid array of 385,000 oligonucleotids 
with a length of 45–60 bp by using maskless array synthesizer 
technology (NimbleGen Systems, Reykjavik, Iceland). In brief:
3   g of genomic DNA of T-ALL sample and a human embryonic 
kidney cell line (HEK-293-T) (as control) were separately labelled 
with cyanine-3 and cyanine-5 dye. Both DNA samples were hy-
bridized to a custom-designed FT-CGH array. The analysis of 
 TRA/D on 14q11.2 (21,130,000–22,130,000; genomic build hg18, 
March 2006) with 19,500 probes and the IGH locus on 14q32 
(105,080,586–106,360,585; genomic build hg18, March 2006) with 
17,000 probes allowed the detection of genetic imbalances in these 
areas by comparing the signal intensity of the test and control 
DNA amount. The high probe density allows the statistic coverage 
of the genome with a hybridization probe of all 400 nucleotides.
 LM-PCR and Sequencing 
 After detection of gains or losses of genetic material upon FT-
CGH, LM-PCR was performed to precisely determine the puta-
tive breakpoint region. In brief, 1   g of high-molecular-weight 
DNA was digested with blunt end restriction enzymes ( Eco RV , 
Dra I,  Pvu II,  Stu I,  Sma I and  Hin dII) and 50   M of an adaptor was 
ligated to both ends of the restriction fragments. The adaptor was 
prepared by hybridization of two oligonucleotides: sense: 5  -GTA 
ATA CGA CTC ACT ATA GGG CAC GCG TGG TCG ACG GCC 
CGG GCT GGT and reverse: 5  -ACC AGC CC-NH 2 . The amine 
group blocks the extension of the 3  -end of the reverse oligonucle-
otide, thereby preventing formation of a primer-binding site on 
non-specific adaptor-ligated restriction fragments and adaptor 
duplexes. The ligation products were subjected to two rounds of 
PCR with nested adaptor-specific primers and two sets of  TRA/D-
 specific primers. The specific primers were located at the borders 
of the deleted regions. After gel electrophoresis PCR bands differ-
ing in size from the germline configuration observed in HEK 293-
T were excised from the gel, purified and directly sequenced. Se-
quence analyses of the regions of interest were performed via the 
University of California Santa Cruz Genome Bioinformatics da-
tabase using BLAT.
 Results 
 Here, we describe the precise molecular characteriza-
tion of a T-ALL case with a split of the  TRA/D found by 
fluorescence in situ hybridization (FISH ) suggesting an 
inv(14)(q11q32). About 68% of cells of this sample showed 
a breakpoint affecting the  TRA/D locus detectable by
recently described  TRA/D FISH probes RPCl11-242H9, 
RPCl11-447G18 and RPCl11-678M7  [2] . FT-CGH of the 
 TRA/D locus was performed in order to precisely clari-
fy the chromosomal aberration. Several mono- and bialle-
lic deletions ( fig.  1 a) were identified between positions 
21,635,000, 21,976,000, 21,989,000 and 22,093,000 within 
the  TRA/D locus. The SignalMap image revealed a com-
plete loss of genetic material of the T-ALL sample on 
14q11.2 between 21,978,000 and 21,989,000. By using two 
round LM-PCR in the region of 21,635,000 with two sets 
of nested forward primers V  1-for(-275) and V  1-for(-69) 
(5  -ACT CAA GCC CAG TCA TCA GT and 5  -CGT CGC 
CTT AAC CAT TTC AG, respectively), we clarified a nor-
mal rearrangement between  TRDV1 and  TRDJ1  (online 
suppl. fig.  2A, for all online suppl. materials, see www.
karger.com/doi/10.1159/000330519) on one allele . This 
breakpoint of  TRDJ1 at position 21,989K was also visible 
in the FT-CGH. This rearrangement was confirmed by 
PCR with the gene specific primers V  1-for(–69) and 
J  1(–189) on undigested genomic DNA (online suppl. 
fig. 2B). To clarify the remaining breakpoint in the area at 
21,976,000 two sets of nested forward gene specific prim-
ers D  2-for(-73) and D  2-for(-41) were used (5  -GGC 
AGC GGG TGG TGA TGG CAA AGT G and 5  -AGA 
GGG TTT TTA TAC TGA TGT, respectively). Sequenc-
ing of atypical fragments of this LM-PCR revealed the in-
version of chromosome 14 with the breakpoints at se-
quence 21,977,838 of 14q11 together with the sequence of 
105,948,661 of 14q32 in the  IGH  locus (online suppl. 
fig. 3A). The joining region consisted of two fused recom-
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bination signal sequences, indicating a signal joint typical 
for a VDJ recombinase-mediated rearrangement. This re-
arrangement was confirmed again using gene-specific 
primers IGHV4-39-f1 (5  -AAA TGA GGT ATA ATG 
GGC TGT GCA GGT AC) and D  2(-73) on undigested 
DNA (online suppl. fig. 3B). Analysis of the breakpoint, 
located downstream of the  TRA/D locus at position of 
22,093,000 by LM-PCR ( fig. 1 b) with reverse gene-specif-
ic primers TRAC-r8/r11 (5  -CAC AAG GCC GTT CTA 
ATT CCC TCT GAC ATA and 5  -CTC TGA GGT TCT 
TGG AGG GGT CTG TCT T, respectively) revealed an 
inversion of 14q11 at position 22,092,696 joined together 
with  IGHV4-61 at 106,166,169 of 14q32.33 (online suppl. 
fig. 4A). Here, the coding segment  IGHV4-61 was fused to 
an intron sequence without a recombination signal se-
quence. This rearrangement was confirmed by regular 
PCR using genomic DNA with primer TRAC-r11 and 
IGHV4-61-r1 (online suppl. fig. 4B). This inversion inv(14)
(q11q32) deleted genomic regions of 114,858 bp within the 
 TRA/D locus and 217,508 bp of the  IGH locus (105,948,661–
106,166,169) ( fig. 1 c). The deletion within the  IGH locus 
was visible in the FT-CGH analysis (online suppl. fig. 5).
a
21
,50
0
21
,60
0
21
,70
0
21
,80
0
21
,90
0
22
,00
0
22
,05
0
21
,95
0
21
,85
0
21
,75
0
21
,65
0
21
,55
0
TRDJ1         TRDV1
22
,10
0
TRDD2 3´-TRAC
FT-CGH:
TRA/D locus
Result: inv(14)(q11q32)
TRD IGH
D1 DAD1 VIII-38-1 V4-61
chr.14
ADHB4
22,092,69221,977,838 106,166,169
V3-62V3-38
83,856,000
V3-62DAD1VIII-38-1 ADHB4
V3-38
105,948,661
V4-61
TRD
V2
IGH 5’
D1V2
D2 V4-39
IGH 3’c
 Fig. 1.  a FT-CGH: TRA/D locus. FT-CGH 
analysis of the TRA/D locus on chromo-
some 14q11 revealed a large monoallelic 
deletion of 458,000 and located within it a 
small biallelic deletion of 11,000. The 
chromosomal localization (in kb) and the 
involved gene segments are indicated. 
Breakpoints of TRD rearrangement are in-
dicating by black arrows. TRA/D break-
points of inv(14)(q11q32) are shown by 
blue arrows.  b LM-PCR with TRAC-r8/r11 
LM-PCR with  Dra I,  Eco RV and  Stu I re-
striction enzymes. G = Germline amplifi-
cation products; R = rearranged frag-
ments; T = T-ALL sample; C = HEK 293-T 
cell line used as a germline control.  c Re-
sult: inv(14)(q11q32). Sequence analysis of 
the atypical rearrangement leading to the 
inv(14)(q11q32). By this inversion  IGHV4–
61 is agminate to a sequence locating the 
3  -end of the constant region of  TRA/D . 
b
LM-PCR with TRAC-r8/r11
Expected germline:
DraI: 825 bp
–
EcoRV: 871 bp
StuI:-
2,000
1,650
1,000
850
650
500
400
300
200
100
1 kb plus       
ladder
1 kb plus             
ladder
2,000
1,650
1,000
850
650
500
400
300
200
100
R
GG
R
Dral Stul EcoRV
T TC C T C neg.
 Clarification of Chromosomal 
Aberrations Using LM-PCR and FT-CGH 
Acta Haematol 2012;127:16–19 19
 References 
 1 Przybylski GK, Dik WA, Grabarczyk P, 
Wanzeck J, Chudobska P, Jankowski K, von 
Bergh A, van Dongen JJ, Schmidt CA, 
Langerak AW: The effect of a novel recombi-
nation between the homeobox gene NKX2–5 
and the TRD locus in T-cell acute lympho-
blastic leukemia on activation of the NKX2–
5 gene. Haematologica 2006; 91: 317–321. 
 2 Gesk S, Martin-Subero JI, Harder L, Luh-
mann B, Schlegelberger B, Calasanz MJ, 
Grote W, Siebert R: Molecular cytogenetic 
detection of  chromosomal breakpoints in T-
cell receptor gene loci. Leukemia 2003; 17: 
 738–745. 
 3 Leich E, Haralambieva E, Zettl A, Chott A, 
Rudiger T, Holler S, Muller-Hermelink HK, 
Ott G, Rosenwald A: Tissue micorarray-
based screening for chromosomal break-
points affecting the T-cell receptor gene loci 
in mature T-cell lymphomas. J Pathol 2007; 
 213: 99–105. 
 4 Kamada N, Sakurai M, Miyamoto K, Sanada 
I, Sadamori N, Fukuhara S, Abe S, Shiraishi 
Y, Abe T, Kaneko Y: Chromosome abnor-
malities in adult T-cell leukemia/lymphoma: 
a Karyotype Review Committee report. 
Cancer Res 1992; 52: 1481–1493. 
 5 Davey MP, Bertness V, Nakahara K, Johnson 
JP, McBride OW, Waldmann TA, Kirsch IR: 
Juxtaposition of the T-cell receptor   -chain 
locus (14q11) and a region (14q32) of poten-
tial importance in leukemogenesis by a 14; 14 
translocation in a patient with T-cell chronic 
lymphocytic leukaemia and ataxia-telangi-
ectasia. Proc Natl Acad Sci USA 1988; 85: 
 9287–9291. 
 6 De Schouwer PJ, Dyer MJ, Brito-Babapulle 
VB, Matutes E, Catovsky D, Yuille MR: T-
cell prolymphocytic leukaemia: antigen re-
ceptor gene rearrangement and a novel mode 
of MTCP1 B1 activation. Br J Haematol 2000; 
 110: 831–838. 
 7 Przybylski GK, Dik WA, Wanzeck J, Grabar-
czyk P, Majunke S, Martin-Subero JI, Siebert 
R, Dolken G, Ludwig WD, Verhaaf B, van 
Dongen JJ, Schmidt CA, Langerak AW: Dis-
ruption of the BCL11B gene through inv(14)
(q11.2q32.31) results in the expression of 
BCL11B-TRDC fusion transcripts and is 
associated with the absence of wild-type 
BCL11B transcripts in T-ALL. Leukemia 
2005; 19: 201–208. 
 8 Boeckx N, Willemse MJ, Szczepanski T, van 
der Velden VH, Langerak AW, Vandekerck-
hove P, van Dongen JJ: Fusion gene tran-
scripts and Ig/TCR gene rearrangements are 
complementary but infrequent targets for 
PCR-based detection of minimal residual 
disease in acute myeloid leukaemia. Leuke-
mia 2002; 16: 368–375. 
 9 Przybylski GK, Dittmann K, Grabarczyk P, 
Dolken G, Gesk S, Harder L, Landmann E, 
Siebert R, Schmidt CA: Molecular character-
ization of a novel chromosomal transloca-
tion t(12; 14)(q23;q11.2) in T-lymphoblastic 
lymphoma between the T-cell receptor delta-
deleting elements (TRDREC and TRAJ61) 
and the hypothetical gene C12orf42. Eur J 
Haematol 2010; 85: 452–456. 
 
 Discussion 
 The inv(14)(q11q32) is a known chromosomal event in 
lymphatic leukaemias such as T cell prolymphocytic leu-
kaemia (T-PLL)  [3] , adult T cell leukaemia  [4] , T cell 
chronic lymphocytic leukaemia and ataxia-telangiecta-
sia  [5] . At the molecular level the inv(14)(q11q32) is very 
heterogeneous. It may involve a large genomic area where 
different genes located at 14q32: the  TCL1A/ TCL1B  (T 
cell leukaemia/lymphoma) in T cell prolymphocytic leu-
kaemia  [6] , the  BCL11B  (B cell CLL/lymphoma 11B) gene 
in T-ALL  [7] and the  IGH locus in pre-B cell acute lym-
phoblastic leukaemia and T-ALL  [4] . The molecular het-
erogeneity may reflect different biology and drug sensi-
tivity of the leukaemic cells with the same translocation. 
Thus, molecular characterization of known chromo-
somal aberrations, including inv(14)(q11q32) may lead to 
better treatment of leukaemia patients. The precise mo-
lecular characterization may allow identification of se-
quences and therefore identification of genes involved in 
chromosomal aberration events and can be used for 
monitoring of minimal residual disease  [8] . The combi-
nation of FT-CGH and LM-PCR allows not only the clar-
ification of known breakpoints precharacterized by 
FISH but also unravels unknown breakpoints. There-
fore, FT-CGH analysis reveals genomic imbalances (de-
letions, amplifications) indicating further chromosomal 
aberrations. These changes can be further clarified by 
LM-PCR and unravel so far missed alterations  [9] . These 
combined techniques can be applied to cell lines as well 
as patient samples with limited percentage of malignant 
cells and may lead to better diagnostic and therapeutic 
options.
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